Cargando…

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is the main prevalent histological type of esophageal cancer, predominantly constituting 90% of cases worldwide. Despite the development of multidisciplinary therapeutic approaches, its prognosis remains unfavorable. Recently, the development of monoclonal a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baba, Yoshifumi, Nomoto, Daichi, Okadome, Kazuo, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Miyamoto, Yuji, Yoshida, Naoya, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469863/ https://www.ncbi.nlm.nih.gov/pubmed/32579769 http://dx.doi.org/10.1111/cas.14541

Ejemplares similares

Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019)

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2019)

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Gut microbiome in gastrointestinal cancer: a friend or foe?
por: Liu, Yang, et al.
Publicado: (2022)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2022)

Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2021)

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
por: Yumoto, Shinsei, et al.
Publicado: (2019)

Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma
por: Sugihara, Hidetaka, et al.
Publicado: (2015)

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
por: Baba, Yoshifumi, et al.
Publicado: (2017)

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma
por: Koga, Yuki, et al.
Publicado: (2015)

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Nakamura, Kenichi, et al.
Publicado: (2016)

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020)

Precautions for avoiding pulmonary morbidity after esophagectomy
por: Yoshida, Naoya, et al.
Publicado: (2020)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer
por: Sugihara, Hidetaka, et al.
Publicado: (2013)

Primary colonic well-differentiated / dedifferentiated liposarcoma of the ascending colon: a case report
por: Sawayama, Hiroshi, et al.
Publicado: (2017)

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow’s node metastasis
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review
por: Yamamura, Kensuke, et al.
Publicado: (2017)

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
por: Harada, Kazuto, et al.
Publicado: (2016)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets
por: Fu, Lingfeng, et al.
Publicado: (2020)

Cancer-related multiple brain infarctions caused by Trousseau syndrome in a patient with metastatic colon cancer: a case report
por: Akiyama, Takahiko, et al.
Publicado: (2016)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cfd4ntfbnpda108e64v9v5dbiq